Latest News

OBIC Business Consultants Co., Ltd. ( TSE:4733 ) shareholders that were waiting for something to happen have been dealt...

JAPAN POST BANK (TSE:7182) is in focus after choosing to act as an anchor investor in the Next Tokai Innovation Fund I, a new ¥5b to ¥6b regional startup investment vehicle. See our latest analysis for JAPAN POST BANK. The fund commitment comes amid a strong run in JAPAN POST BANK's shares, with a 30 day share price return of 24.78% and a 90 day share price return of 60.23%. The 1 year total shareholder return of 85.38% and 5 year total shareholder return of 253.95% point to sustained gains...

As you might know, Central Japan Railway Company ( TSE:9022 ) just kicked off its latest quarterly results with some...

East Japan Railway Company ( TSE:9020 ) came out with its third-quarter results last week, and we wanted to see how the...

Despite an already strong run, Hitachi Construction Machinery Co., Ltd. ( TSE:6305 ) shares have been powering on, with...

Despite an already strong run, Nisshinbo Holdings Inc. ( TSE:3105 ) shares have been powering on, with a gain of 27% in...

TDK Corporation ( TSE:6762 ) investors will be delighted, with the company turning in some strong numbers with its...

As you might know, Kyocera Corporation ( TSE:6971 ) just kicked off its latest third-quarter results with some very...

The simplest way to benefit from a rising market is to buy an index fund. When you buy individual stocks, you can make...

Yancoal Australia Ltd ( ASX:YAL ) shareholders would be excited to see that the share price has had a great month...

Teradyne’s FY 2025 Earnings Snapshot Teradyne (TER) has wrapped up FY 2025 with fourth quarter revenue of US$1.1 billion and basic EPS of US$1.64, setting the tone for how investors assess the latest move in profitability. The company has seen quarterly revenue move from US$752.9 million in Q4 2024 to US$1.1 billion in Q4 2025, while basic EPS shifted from US$0.90 to US$1.64 over the same period, providing a clear view of how the top and bottom line have tracked together. With a trailing 12...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...

Key Insights Beetaloo Energy Australia's significant retail investors ownership suggests that the key decisions are...

Bravura Solutions Limited ( ASX:BVS ) shareholders that were waiting for something to happen have been dealt a blow...

Despite the fact that Quantum-Si incorporated's (NASDAQ:QSI) value has dropped 11% in the last week insiders who sold...

CITIC Telecom International Holdings announced that Chief Financial Officer and Executive Director Mr. Luan Zhenjun resigned from both roles on January 30, 2026, citing other work arrangements and prompting a search for his replacement. This simultaneous departure from the finance leadership and the board raises questions about continuity in financial oversight and decision-making at the company. We will now examine how the resignation of the long-serving Chief Financial Officer shapes CITIC...

If you are looking at Arrowhead Pharmaceuticals and wondering whether the recent excitement matches the stock's underlying value, this article will walk you through the key signals to watch. The share price sits at US$72.14 after returns of 7.8% over the past week, 6.4% over the past month, 6.4% year to date, 266.6% over the past year and 114.6% over three years, while the five year return is negative at 19.7%. Recent coverage around Arrowhead has focused on its progress in RNA interference...

Essity has completed the acquisition of Edgewell Personal Care’s feminine care business. The deal adds brands such as Carefree, Stayfree, o.b., and Playtex to Essity’s portfolio in North America. The transaction strengthens Essity’s position in the high margin feminine hygiene segment in the U.S. and wider North American market. Essity, traded as OM:ESSITY B, is leaning further into personal care categories that carry higher margins, with a current share price of SEK273.8. The company is...

ZipRecruiter, Inc. ( NYSE:ZIP ) shareholders that were waiting for something to happen have been dealt a blow with a...

Key Insights Institutions' substantial holdings in Treace Medical Concepts implies that they have significant influence...

As the Australian market faces headwinds from a recent Reserve Bank rate hike and global tech sell-offs, small-cap stocks are navigating a challenging landscape. In this environment, identifying promising opportunities involves looking for companies with robust fundamentals and potential resilience to economic shifts.

The Australian market is facing headwinds as the Reserve Bank's recent rate hike and global tech sell-offs weigh on investor sentiment, with ASX 200 futures indicating a potential downturn. Despite these challenges, opportunities persist in the form of penny stocks, which offer unique investment prospects due to their lower price points and potential for growth. While the term "penny stocks" might seem outdated, these smaller or newer companies can present significant upside when backed by...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Embla Medical hf (CPSE:EMBLA) has wrapped up FY 2025 with fourth quarter revenue of US$256.7 million and basic EPS of US$0.058, on trailing twelve month revenue of US$928.7 million and EPS of US$0.196 that frame the latest print. Over recent periods the company has seen revenue move from US$224.8 million and EPS of roughly US$0.044 in Q4 2024 to US$256.7 million and EPS of US$0.058 in Q4 2025, with trailing net income rising from US$68.3 million to US$83.3 million. This sets up a story where...